Excellent response and real insight into the lack of buys.
We just need to let the trading forces at work play themselves out before we see what could very well be a major upward move. There's so much actually going on behind the scenes that are effecting the share price and trading and that coupled with the confusion it creates among the unknowing retail trade, all comprise the current trading picture, imo.
The lack of a strong positive market reaction to the long awaited TLD data in the Lancet article, while mystifying, imo, then becomes more understandable given the above statements.
I am of the feeling that we rely on conjecture on developments going forward as stated and conjectured by the likes of Lasers, Reetala, North, etc., that we continue to believe in management truly trying to turn this company around to becoming a commercial entity and going along again with their proxy request for more shares under the assumption that it's a definite part of their business plan for uplisting and eventual partnering, but that feelings about management financial perks vote are up to each individual's feelings and assesment.
News 
Market Data 
Discover 
